Rafael Amado
age ~62
from Los Angeles, CA
- Also known as:
-
- Rafael Deras
- Rafael Amamdo
Rafael Amado Phones & Addresses
- Los Angeles, CA
- Beverly Hills, CA
- Hawthorne, CA
- 606 N Oxford Ave APT 305, Los Angeles, CA 90004 • 323-481-2359
Emails
Resumes
President At Invex Now
view sourcePosition:
President at INVEX NOW
Location:
Greater Los Angeles Area
Industry:
International Trade and Development
Work:
INVEX NOW - Greater Los Angeles Area since Feb 2007
President
INVEX 2008 - 2010
President
The Amder Group Jan 1996 - Jun 2009
Bilingual Media Consultant
President
INVEX 2008 - 2010
President
The Amder Group Jan 1996 - Jun 2009
Bilingual Media Consultant
Education:
Universidad de San Carlos de Guatemala 1997 - 2001
BA, Social Communications UCLA 1991 - 1996
Bachelor of Science (BS), Communication and Media Studies
BA, Social Communications UCLA 1991 - 1996
Bachelor of Science (BS), Communication and Media Studies
Interests:
INVEX was formed in Los Angeles, California with the solely intention of promoting and licensing inventions of all kind, primarily in United States and on a second phase will expand operations to countries like China, Japan and Europe.
Honor & Awards:
On the professional side and sports, a few.
Experienced Bilingual Media Consultant
view sourceLocation:
606 north Oxford Ave, Los Angeles, CA 90004
Industry:
Media Production
Work:
Strommen Inc.
Spanish Teacher
Sos International Jan 2017 - Dec 2018
Immigration Court Interpreter
Mochilero Road Jan 2017 - Dec 2018
Entrepreneur
Department of Elections Sep 2016 - Nov 2016
Elections Assistant
The Amder Group Jan 1996 - Jun 2009
Bilingual Media Consultant
Spanish Teacher
Sos International Jan 2017 - Dec 2018
Immigration Court Interpreter
Mochilero Road Jan 2017 - Dec 2018
Entrepreneur
Department of Elections Sep 2016 - Nov 2016
Elections Assistant
The Amder Group Jan 1996 - Jun 2009
Bilingual Media Consultant
Education:
Universidad De San Carlos De Guatemala 1997 - 2001
Bachelors, Bachelor of Arts, Bachelor of Science, Communications University of California, Los Angeles 1991 - 1996
Bachelors, Bachelor of Science, Media Studies, Communication University of California, Los Angeles 1993 - 1995
The American Film Institute 1992 - 1993
Associates
Bachelors, Bachelor of Arts, Bachelor of Science, Communications University of California, Los Angeles 1991 - 1996
Bachelors, Bachelor of Science, Media Studies, Communication University of California, Los Angeles 1993 - 1995
The American Film Institute 1992 - 1993
Associates
Skills:
Video Production
Editorial
Broadcast
Media Production
Photography
Publications
Social Media
Social Networking
Tv Production
Translation
Interpreting
Graphic Design
Public Relations
Marketing Strategy
Business Strategy
New Business Development
Strategic Planning
Business Development
Social Media Marketing
Editorial
Broadcast
Media Production
Photography
Publications
Social Media
Social Networking
Tv Production
Translation
Interpreting
Graphic Design
Public Relations
Marketing Strategy
Business Strategy
New Business Development
Strategic Planning
Business Development
Social Media Marketing
Interests:
Electronics
Sweepstakes
Reading
Japan and Europe
Automobiles
Invex Was Formed In Los Angeles
Travel
Sweepstakes
Reading
Japan and Europe
Automobiles
Invex Was Formed In Los Angeles
Travel
Languages:
Spanish
English
English
Certifications:
Interpreter Federal Immigration Court
Master Degree Student
view sourceLocation:
Menlo Park, CA
Industry:
Telecommunications
Work:
Synchromedia Laboratory For Multimedia Communication In Telepresence
Master Degree Student
Hughes Do Brasil Apr 2018 - Apr 2019
Telecommunications Engineer
Univesp Sep 2014 - Apr 2018
Engineer and Contract Manager
Sky Brasil May 2014 - Aug 2014
Core Engineer Specialist
Claro Dec 2012 - Apr 2014
Senior Engineer
Master Degree Student
Hughes Do Brasil Apr 2018 - Apr 2019
Telecommunications Engineer
Univesp Sep 2014 - Apr 2018
Engineer and Contract Manager
Sky Brasil May 2014 - Aug 2014
Core Engineer Specialist
Claro Dec 2012 - Apr 2014
Senior Engineer
Education:
École De Technologie Supérieure 2019 - 2021
Master of Science, Masters Universidade Paulista 2016 - 2018
Universidade Federal Do Rio De Janeiro 2009 - 2012
Master of Science, Masters Universidade Estadual Paulista Júlio De Mesquita Filho 2004 - 2008
Bachelors, Bachelor of Science, Electrical Engineering Universidad De La República 2008 - 2008
Master of Science, Masters Universidade Paulista 2016 - 2018
Universidade Federal Do Rio De Janeiro 2009 - 2012
Master of Science, Masters Universidade Estadual Paulista Júlio De Mesquita Filho 2004 - 2008
Bachelors, Bachelor of Science, Electrical Engineering Universidad De La República 2008 - 2008
Skills:
Telecommunications
Lte
Linux
3G
Mobile Devices
Gsm
Tcp/Ip
Matlab
Gprs
Engineering
Microsoft Office
Networking
Open Source Software
Cisco Technologies
Troubleshooting
Wireless
Teamwork
Windows
Training Delivery
4G
Umts
Ip
Mobile Communications
2G
Technical Training
Switches
Internet Protocol
Wireless Technologies
3Gpp
Operating Systems
Routers
Electrical Engineering
Vsat
Core Network
Lte
Linux
3G
Mobile Devices
Gsm
Tcp/Ip
Matlab
Gprs
Engineering
Microsoft Office
Networking
Open Source Software
Cisco Technologies
Troubleshooting
Wireless
Teamwork
Windows
Training Delivery
4G
Umts
Ip
Mobile Communications
2G
Technical Training
Switches
Internet Protocol
Wireless Technologies
3Gpp
Operating Systems
Routers
Electrical Engineering
Vsat
Core Network
Interests:
Science and Technology
Languages:
Portuguese
Spanish
English
French
Spanish
English
French
Certifications:
Cisco, License Csco12470712
Cisco Certified Network Associate (Ccna)
License Csco12470712
Cisco Certified Network Associate (Ccna)
License Csco12470712
Rafael Amado
view source
Rafael Franco Amado
view source
Rafael Amado
view sourceLocation:
United States
Us Patents
-
Methods For Genetic Modification Of Hematopoietic Progenitor Cells And Uses Of The Modified Cells
view source -
US Patent:7776595, Aug 17, 2010
-
Filed:Aug 18, 2006
-
Appl. No.:11/506722
-
Inventors:Geoffrey P. Symonds - Rosebay, AU
Rafael G. Amado - Encino CA, US
Lun-Quan Sun - Eastwood, AU
Janet L. MacPherson - Leichhardt, AU
Gregory C. Fanning - Bronte, AU
Wayne Gerlach - Killara, AU -
Assignee:Johnson & Johnson Research Pty, Limited - Eveleigh
-
International Classification:C12N 5/08
C12N 15/63
C12Q 1/68
A01N 43/04
C07H 21/04 -
US Classification:435372, 435 6, 435 911, 435 9131, 435455, 435458, 514 1, 514 44, 536 231, 536 245
-
Abstract:Described are compositions and methods relating to gene therapy, particularly as applied to hematopoietic progenitor (HP) cells, to transduced cells and methods of obtaining them, and to methods of using them to provide prolonged engraftment of modified hematopoietic cells in human subjects. The invention particularly relates to ex vivo gene therapy of HP cells for treatment or prevention of HIV infection.
-
Methods For Genetic Modification Of Hematopoietic Progenitor Cells And Uses Of The Modified Cells
view source -
US Patent:20040072771, Apr 15, 2004
-
Filed:Jul 10, 2002
-
Appl. No.:10/192980
-
Inventors:Geoffrey Symonds - Rosebay, AU
Rafael Amado - Encino CA, US
Lun -Quan Sun - Eastwood, AU
Janet MacPherson - Leichhardt, AU
Gregory Fanning - Bronte, AU
Wayne Gerlach - East Killara, AU -
International Classification:A61K048/00
-
US Classification:514/044000, 424/093210
-
Abstract:Described are compositions and methods relating to gene therapy, particularly as applied to hematopoietic progenitor (HP) cells, to transduced cells and methods of obtaining them, and to methods of using them to provide prolonged engraftment of modified hematopoietic cells in human subjects. The invention particularly relates to ex vivo gene therapy of HP cells for treatment or prevention of HIV infection.
-
Process For The Preparation Of A Composition Of Genetically Modified Hematopoietic Progenitor Cells
view source -
US Patent:20130344040, Dec 26, 2013
-
Filed:Jul 8, 2013
-
Appl. No.:13/936781
-
Inventors:Geoffrey P. Symonds - Rose Bay, AU
Rafael Amado - Encino CA, US
Lun-Quan Sun - Eastwood, AU
Janet Macpherson - Leichhardt, AU
Greg Fanning - Surry Hills, AU
Wayne Gerlach - East Killara, AU -
Assignee:JOHNSON & JOHNSON RESEARCH PTY. LIMITED - Eveleigh
-
International Classification:A61K 48/00
-
US Classification:424 9321
-
Abstract:Described are compositions and methods relating to gene therapy, particularly as applied to hematopoietic progenitor (HP) cells, to transduced cells and methods of obtaining them, and to methods of using them to provide prolonged engraftment of modified hematopoietic cells in human subjects. The invention particularly relates to ex vivo gene therapy of HP cells for treatment or prevention of HIV infection.
Youtube
Rafael Amado
view source
Jaime Rafael Amado Pinto
view source
Rafael Amado Aquino Paredes
view source
Rafael Amado Snchez
view source
Rafael Amado
view source
Rafael Amado
view source
Cesar Rafael Amado Muoz
view source
Rafael Amado
view sourceNews
FDA Grants T-Cell Therapy Breakthrough Designation in Sarcoma
view source- e are pleased that the FDA has granted breakthrough therapy designation for our T-cell therapy in synovial sarcoma, recognizing both the unmet need for patients suffering from this disease as well as the promise of these early data, said Rafael Amado, MD, chief medical officer at Adaptimmune. We l
- Date: Feb 09, 2016
- Category: Health
- Source: Google
Adaptimmune wins 'breakthrough' tag
view source- "We are pleased that the FDA has granted breakthrough therapy designation for our T-cell therapy in synovial sarcoma, recognizing both the unmet need for patients suffering from this disease as well as the promise of these early data," said Rafael Amado, Adaptimmune's chief medical officer. "We look
- Date: Feb 09, 2016
- Category: Health
- Source: Google
U.S. Food and Drug Administration Grants Breakthrough Therapy Designation for Adaptim...
view source- re pleased that the FDA has granted Breakthrough Therapy designation for our T-cell therapy in synovial sarcoma, recognizingboth the unmet need for patientssuffering from this disease as well asthe promise of these early data, saidDr. Rafael Amado, Adaptimmunes Chief Medical Officer.We look
- Date: Feb 09, 2016
- Category: Health
- Source: Google
Scheduled Conference Calls, License Agreements, Dividends, Preliminary ...
view source- patients during the first four cycles of treatment. Dr. Rafael Amado, Senior Vice President Oncology R&D at GSK, said, "Cytopenias are important complications of MDS which tend to worsen with azacitidine treatment. Currently, there are no approved treatments for MDS that stimulate platelet production.
- Date: Jun 30, 2014
- Category: Business
- Source: Google
GSK and Genmab announce top-line results from a Phase III study of ...
view source- scientific community as soon it became available. We will now work to further analyse the data and to better understand the totality of the efficacy and safety findings," said Dr. Rafael Amado, Head of Oncology R&D at GSK. "We are very grateful to the CLL patients who participated in this trial.
- Date: Jun 27, 2014
- Category: Health
- Source: Google
Glaxo's Arzerra Lukemia Drug Misses Key Target in Clinical Trial
view source- It was our priority to share this result with the scientific community as soon as it became available, said Dr. Rafael Amado, head of oncology R&D at Glaxo. We will now work to further analyze the data and to better understand the totality of the efficacy and safety findings.
- Date: Jun 27, 2014
- Category: Health
- Source: Google
Tykerb, Avastin suffer disappointing data at SABCS
view source- had a slightly improved rate of progression-free survival, the difference when compared with placebo wasn't statistically significant. "Although we are disappointed,"GSK SVP Rafael Amado said, "[Tykerb] remains an important treatment option for patients with metastasis HER2-positive breast cancer."
- Date: Dec 09, 2011
- Category: Health
- Source: Google
Flickr
Googleplus
Rafael Amado
Rafael Amado
Rafael Amado
Get Report for Rafael Amado from Los Angeles, CA, age ~62